These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27519462)

  • 1. Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
    Valenciano AL; Ramsey AC; Santos WL; Mackey ZB
    Bioorg Med Chem; 2016 Oct; 24(19):4647-4651. PubMed ID: 27519462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular-signal regulated kinase 8 of Trypanosoma brucei uniquely phosphorylates its proliferating cell nuclear antigen homolog and reveals exploitable properties.
    Valenciano AL; Knudsen GM; Mackey ZB
    Cell Cycle; 2016 Oct; 15(20):2827-41. PubMed ID: 27589575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.
    Bayliss T; Robinson DA; Smith VC; Brand S; McElroy SP; Torrie LS; Mpamhanga C; Norval S; Stojanovski L; Brenk R; Frearson JA; Read KD; Gilbert IH; Wyatt PG
    J Med Chem; 2017 Dec; 60(23):9790-9806. PubMed ID: 29125744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical proteomic analysis reveals the drugability of the kinome of Trypanosoma brucei.
    Urbaniak MD; Mathieson T; Bantscheff M; Eberhard D; Grimaldi R; Miranda-Saavedra D; Wyatt P; Ferguson MA; Frearson J; Drewes G
    ACS Chem Biol; 2012 Nov; 7(11):1858-65. PubMed ID: 22908928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
    Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
    J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules.
    Woodland A; Grimaldi R; Luksch T; Cleghorn LA; Ojo KK; Van Voorhis WC; Brenk R; Frearson JA; Gilbert IH; Wyatt PG
    ChemMedChem; 2013 Jul; 8(7):1127-37. PubMed ID: 23776181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirubin Analogues Inhibit
    Efstathiou A; Gaboriaud-Kolar N; Myrianthopoulos V; Vougogiannopoulou K; Subota I; Aicher S; Mikros E; Bastin P; Skaltsounis AL; Soteriadou K; Smirlis D
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.
    Pham T; Walden M; Butler C; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Gomez-Pérez V; García-Hernández R; Zecca H; Krakoff E; Kopec B; Ichire O; Mackenzie C; Pitot M; Ruiz LM; Gamarro F; González-Pacanowska D; Navarro M; Dounay AB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3629-3635. PubMed ID: 28729055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of the extracellular-signal regulated kinase 8 homolog in Trypanosoma brucei in vivo reduces its virulence in a mouse target validation study.
    Elaadli H; Kim I; Mackey ZB
    Mol Biochem Parasitol; 2018 Mar; 220():1-4. PubMed ID: 29287675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
    Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
    Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign.
    Diaz R; Luengo-Arratta SA; Seixas JD; Amata E; Devine W; Cordon-Obras C; Rojas-Barros DI; Jimenez E; Ortega F; Crouch S; Colmenarejo G; Fiandor JM; Martin JJ; Berlanga M; Gonzalez S; Manzano P; Navarro M; Pollastri MP
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3253. PubMed ID: 25340575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
    Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
    Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
    Bland ND; Wang C; Tallman C; Gustafson AE; Wang Z; Ashton TD; Ochiana SO; McAllister G; Cotter K; Fang AP; Gechijian L; Garceau N; Gangurde R; Ortenberg R; Ondrechen MJ; Campbell RK; Pollastri MP
    J Med Chem; 2011 Dec; 54(23):8188-94. PubMed ID: 22023548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.
    Cleghorn LA; Albrecht S; Stojanovski L; Simeons FR; Norval S; Kime R; Collie IT; De Rycker M; Campbell L; Hallyburton I; Frearson JA; Wyatt PG; Read KD; Gilbert IH
    J Med Chem; 2015 Oct; 58(19):7695-706. PubMed ID: 26418485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Antiplasmodial 2-Aminopyridines as Potential Antitrypanosomal Agents.
    Veale CGL; Laming D; Swart T; Chibale K; Hoppe HC
    ChemMedChem; 2019 Dec; 14(24):2034-2041. PubMed ID: 31670464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-organism high-throughput screening against Trypanosoma brucei brucei.
    Jones AJ; Avery VM
    Expert Opin Drug Discov; 2013 May; 8(5):495-507. PubMed ID: 23540598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei.
    Sun YN; No JH; Lee GY; Li W; Yang SY; Yang G; Schmidt TJ; Kang JS; Kim YH
    Molecules; 2016 Apr; 21(4):480. PubMed ID: 27077842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.